Eos Advisory

St Andrews-based impact investment firm Eos Advisory has secured a commitment of up to £10 million from British Business Investments, a commercial subsidiary of the British Business Bank. The investment, facilitated through the Regional Angels Programme, will be deployed alongside Eos’s

Dxcover — a Glasgow-based company developing a blood test that can detect cancer at an early stage — has raised £9.7 million through a Series A investment round and grant funding. The £7.5m funding round was led by existing investors Eos Advisory LLP, Mercia Asset M

Scottish startup Waire Health has received £2 million in funding from St Andrews-based Eos Advisory and Scottish Enterprise. The investment will allow the firm to scale its sensor technology and grow its management team, production, and product development capabilities, while enablin

Green Bioactives Ltd (GBL), a Edinburgh-based firm dedicated to the discovery, development and sustainable production of high-value natural products derived from plant cell cultures, has successfully completed a £2.6 million seed financing round. The funding round was led by Eos Advisory LLP a

Cleantech start-up Penrhos Bio has secured a £1 million investment with the support of St Andrews-based impact investment firm Eos Advisory. The investment will accelerate the commercialisation of its patented platform technology, RemoraTM, developed in collaboration with Unilever, that protec

St Andrews-based investment firm Eos Advisory has strengthened its team, with Andrew Durkie joining as a partner, and Andy Lothian and Sandy Kennedy appointed as non-executive growth advisors. Andrew Durkie is a chartered accountant who brings over twenty years’ experience in mergers and

Edinburgh-based life sciences company Carcinotech, a MedTech specialist in the manufacture of 3D printed tumours developed from cancer stem cells, primary cells, and established cell lines, has secured a £1.6 million investment from leading Scotland-based investors to accelerate commercialisat

Burges Salmon’s Corporate Finance team has advised oncology drug discovery accelerator, Cumulus Oncology Limited, on a significant investment fundraise of c. £4.1 million. The investment fundraise follows Cumulus Oncology’s inaugural investment fundraise of £1.7m, which Burge

St Andrews-based investment firm Eos Advisory's portfolio has reached a total valuation of £121 million based on latest investment rounds, and saw its first two exit events in 2021. In January 2021, Eos announced that it had led a £1.24m investment into RAB-Microfluidics, an Aberdeen-hea

RiboNucleic Acid (RNA) sequencing specialist Wobble Genomics has raised a £1.2 million investment round led by Eos Advisory. Wobble is a spin-out from the University of Edinburgh’s Roslin Institute, was founded by CEO Richard Kuo in April 2021, and has developed a range of hardware and s

St Andrews-based investment firm Eos Advisory is set for further growth in 2021 after a record year of activity in 2020. The firm’s focus is on impact investment in Scottish science, engineering and technology innovation while building co-investor partnerships and encouraging inward investment

Glasgow-based ClinSpec Diagnostics Limited (ClinSpec Dx) has reached its round two funding target of £3.5 million by securing an additional investment of £1.1m. The firm which develops liquid biopsies for early detection of cancer has secured the £1.1m investment from Norcliffe Cap

St Andrews-based investment firm Eos Advisory has entered into a strategic partnership with US-based Kineticos Life Sciences to co-invest in early stage Scottish life sciences companies. The venture partnership aims to invest over £10 million over the next five years in oncology-focused life s

Chris Brinsmead CBE, the former senior AstraZeneca executive and experienced non-executive director, has joined St Andrews-based investment firm Eos Advisory as a partner. Mr Brinsmead is a council member at Imperial College London, a former adviser to the UK Government on life sciences, has pr

Dundee-based sports video game developer Digital Sports Arena has secured a global publishing deal with international games group Playstack for its latest game, GameDayLive.